Medullary thyroid carcinoma: recent advances in identification, treatment, and prognosis
Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor that represents <5% of all thyroid malignancies and is generally more aggressive than differentiated thyroid cancer. The aim of this study is to provide an update, through review of clinical studies of patients with MTC published between...
Main Authors: | Marisa A. Bartz-Kurycki, Omowunmi E. Oluwo, Lilah F. Morris-Wiseman |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-10-01
|
Series: | Therapeutic Advances in Endocrinology and Metabolism |
Online Access: | https://doi.org/10.1177/20420188211049611 |
Similar Items
-
Recent Updates on the Management of Medullary Thyroid Carcinoma
by: Bo Hyun Kim, et al.
Published: (2016-09-01) -
Recent Advances in Renal Medullary Carcinoma
by: Yongdong Su, et al.
Published: (2022-06-01) -
Kinase inhibitors for advanced medullary thyroid carcinoma
by: Martin Schlumberger, et al.
Published: (2012-01-01) -
MEDULLARY THYROID CARCINOMA
by: V. S. Medvedev, et al.
Published: (2015-04-01) -
Thyroid Collision Tumors: The Presence of the Medullary Thyroid Carcinoma Component Negatively Influences the Prognosis
by: Ion Negura, et al.
Published: (2023-01-01)